THE MULTIDRUG-RESISTANCE-REVERSER VERAPAMIL INTERFERES WITH CELLULAR P-GLYCOPROTEIN-MEDIATED PUMPING OF DAUNORUBICIN AS A NON-COMPETING SUBSTRATE

被引:82
作者
SPOELSTRA, EC
WESTERHOFF, HV
PINEDO, HM
DEKKER, H
LANKELMA, J
机构
[1] FREE UNIV AMSTERDAM HOSP,DEPT MED ONCOL,1081 HV AMSTERDAM,NETHERLANDS
[2] UNIV AMSTERDAM,NETHERLANDS CANC INST,DIV MOLEC BIOL,AMSTERDAM,NETHERLANDS
[3] UNIV AMSTERDAM,BIOCENTRUM,EC SLATER INST BIOCHEM RES,AMSTERDAM,NETHERLANDS
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 1994年 / 221卷 / 01期
关键词
D O I
10.1111/j.1432-1033.1994.tb18748.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We examined P-glycoprotein-mediated verapamil transport, using two drug-sensitive and multidrug resistant cell-line couples, i.e. A2780, 2780(AD) and SW-1573, SW-1573/1R500. The interaction of H-3-labeled verapamil with cells was measured using a flow-through system. The verapamil-containing medium was pumped over the cells and monitored on-line for radioactivity. In the P-glycoprotein-expressing cells, verapamil accumulation was increased by vinblastine and some known multidrug resistant (MDR) modifiers. Subsequent removal of these modifiers caused release of verapamil into the medium against a verapamil concentration gradient. In this manner, we obtained evidence that verapamil is actively transported by the MDR-related P-glycoprotein. Using the flow-through system, we also exposed the cells to flowing culture medium containing daunorubicin, and measured the inhibition of daunorubicin efflux by verapamil. We found that, although the active efflux of daunorubicin was maximally blocked by verapamil short-term, longer-term active efflux of daunorubicin resumed. At a daunorubicin concentration in the flowing medium of 5 mu M, increasing the verapamil concentration resulted in the same short-term effects, but in a significantly longer period of a maximal inhibition of daunorubicin efflux from the cells. At a daunorubicin concentration of 20 mu M, increasing the verapamil concentration affected neither the short-term nor the long-term effects. These and other observations are in agreement with a model in which daunorubicin and verapamil are non-competing substrates for P-glycoprotein. In conclusion, we obtained evidence that verapamil is actively transported by the MDR-related P-glycoprotein and that verapamil and daunorubicin are non-competing substrates for P-glycoprotein. Consequently, the effectiveness of verapamil as an MDR antagonist may be compromised because it is extruded by P-glycoprotein.
引用
收藏
页码:363 / 373
页数:11
相关论文
共 43 条
  • [1] MULTIDRUG RESISTANCE AND ITS CIRCUMVENTION
    BECK, WT
    [J]. EUROPEAN JOURNAL OF CANCER, 1990, 26 (04) : 513 - 515
  • [2] MECHANISM OF MULTIDRUG RESISTANCE
    BRADLEY, G
    JURANKA, PF
    LING, V
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1988, 948 (01) : 87 - 128
  • [3] INDUCTION BY VERAPAMIL OF A RAPID INCREASE IN ATP CONSUMPTION IN MULTIDRUG-RESISTANT TUMOR-CELLS
    BROXTERMAN, HJ
    PINEDO, HM
    KUIPER, CM
    KAPTEIN, LCM
    SCHUURHUIS, GJ
    LANKELMA, J
    [J]. FASEB JOURNAL, 1988, 2 (07) : 2278 - 2282
  • [4] IMMUNOHISTOCHEMICAL DETECTION OF P-GLYCOPROTEIN IN HUMAN-TUMOR CELLS WITH A LOW DEGREE OF DRUG-RESISTANCE
    BROXTERMAN, HJ
    PINEDO, HM
    KUIPER, CM
    VANDERHOEVEN, JJM
    DELANGE, P
    QUAK, JJ
    SCHEPER, RJ
    KEIZER, HG
    SCHUURHUIS, GJ
    LANKELMA, J
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (02) : 340 - 343
  • [5] BROXTERMAN HJ, 1991, J CELL PHARM, V2, P239
  • [6] BRUGGEMANN EP, 1989, J BIOL CHEM, V264, P15483
  • [7] ACTION OF CALCIUM-ANTAGONISTS ON MULTIDRUG RESISTANT CELLS - SPECIFIC CYTOTOXICITY INDEPENDENT OF INCREASED CANCER DRUG ACCUMULATION
    CANOGAUCI, DF
    RIORDAN, JR
    [J]. BIOCHEMICAL PHARMACOLOGY, 1987, 36 (13) : 2115 - 2123
  • [8] MEMBRANE-VESICLES FROM MULTIDRUG-RESISTANT HUMAN CANCER-CELLS CONTAIN A SPECIFIC 150-KDA TO 170-KDA PROTEIN DETECTED BY PHOTOAFFINITY-LABELING
    CORNWELL, MM
    SAFA, AR
    FELSTED, RL
    GOTTESMAN, MM
    PASTAN, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (11) : 3847 - 3850
  • [9] DRUG-RESISTANCE IN MULTIPLE-MYELOMA AND NON-HODGKINS LYMPHOMA - DETECTION OF P-GLYCOPROTEIN AND POTENTIAL CIRCUMVENTION BY ADDITION OF VERAPAMIL TO CHEMOTHERAPY
    DALTON, WS
    GROGAN, TM
    MELTZER, PS
    SCHEPER, RJ
    DURIE, BGM
    TAYLOR, CW
    MILLER, TP
    SALMON, SE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (04) : 415 - 424
  • [10] DEUCHARS KL, 1989, SEMIN ONCOL, V16, P156